| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |